Monthly Archives: October 2023

Genprex to Host a Virtual Key Opinion Leader Event on “Bringing Gene Therapy  to the Fight Against Lung Cancers”

Webinar to be held on Friday, October 27, 2023 from 12:30 pm – 1:45 pm Eastern Time

Read More

Genprex to Present Data on the Use of REQORSA® for the Treatment of Lung Cancers at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Acclaim-1 Phase 1 study had no Dose Limiting Toxicity, and results establish Phase 2 Recommended Dose as well as provide data showing efficacy of REQORSA® in combination with Tagrisso®

Read More

How Strategically Partnering With Academia Supports Biotech R&D Goals

Genprex’s Chief Financial Officer, Ryan Confer, shares his insight on partnering with academic institutions, the benefits, and best practices

Read More